The global Next Generation Sequencing (NGS) market is experiencing rapid growth, propelled by advancements in genomic technologies, increasing applications in clinical diagnostics, and the rising demand for personalized medicine. NGS technologies have revolutionized the field of genomics by enabling high-throughput, cost-effective, and accurate sequencing, facilitating a deeper understanding of genetic variations and their implications in health and disease.
Global Next Generation Sequencing Market size and share is currently valued at USD 9.90 Billion in 2024 and is anticipated to generate an estimated revenue of USD 43.42 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 20.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032
Market Overview
NGS technologies have become integral in various sectors, including oncology, infectious disease research, reproductive health, and genetic disorder diagnostics. The ability to sequence entire genomes or specific regions with high precision has opened new avenues in research and clinical applications. The market’s expansion is further supported by the decreasing cost of sequencing, making these technologies more accessible to a broader range of institutions and healthcare providers.
Growth Drivers
Several factors are contributing to the robust growth of the NGS market:
- Advancements in Sequencing Technologies: Continuous innovations, such as the development of long-read sequencing and nanopore technologies, have enhanced the accuracy and efficiency of genomic analyses.
- Integration with Artificial Intelligence: The incorporation of AI and machine learning algorithms in NGS data analysis has streamlined the interpretation of complex genomic data, facilitating faster and more accurate diagnostics.
- Rising Prevalence of Genetic Disorders: The increasing incidence of genetic diseases has heightened the demand for comprehensive genomic testing, positioning NGS as a critical tool in early diagnosis and personalized treatment strategies.
- Expansion in Emerging Markets: Developing regions are investing in healthcare infrastructure and genomic research, presenting significant opportunities for NGS adoption and market penetration.
Market Segmentation
Global Next Generation Sequencing Market Assessment by Application
5.1. Key Findings
5.2. Introduction
5.2.1. Global Next Generation Sequencing Market, By Application, 2019 – 2032 (USD Billion)
5.3. Drug Discovery/Personalized Medicine
5.3.1. Global Next Generation Sequencing Market, by Drug Discovery/Personalized Medicine, by Region, 2019 – 2032 (USD Billion)
5.4. Genetic Screening
5.4.1. Global Next Generation Sequencing Market, by Genetic Screening, by Region, 2019 – 2032 (USD Billion)
5.5. Diagnostics/Infectious Diseases
5.5.1. Global Next Generation Sequencing Market, by Diagnostics/Infectious Diseases, by Region, 2019 – 2032 (USD Billion)
5.6. Agricultural & Animal Research
5.6.1. Global Next Generation Sequencing Market, by Agricultural & Animal Research, by Region, 2019 – 2032 (USD Billion)
5.7. Others
5.7.1. Global Next Generation Sequencing Market, by Others, by Region, 2019 – 2032 (USD Billion)
Global Next Generation Sequencing Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Next Generation Sequencing Market, By Technology, 2019 – 2032 (USD Billion)
6.3. Whole Genome
6.3.1. Global Next Generation Sequencing Market, by Whole Genome, By Region, 2019 – 2032 (USD Billion)
6.4. Targeted Sequencing & Re-sequencing
6.4.1. Global Next Generation Sequencing Market, by Targeted Sequencing & Re-sequencing, by Region, 2019 – 2032 (USD Billion)
6.5. Whole Exome
6.5.1. Global Next Generation Sequencing Market, by Whole Exome, by Region, 2019 – 2032 (USD Billion)
6.6. RNA Sequencing
6.6.1. Global Next Generation Sequencing Market, by RNA Sequencing, by Region, 2019 – 2032 (USD Billion)
6.7. Chip Sequencing
6.7.1. Global Next Generation Sequencing Market, by Chip Sequencing, by Region, 2019 – 2032 (USD Billion)
6.8. De Novo Sequencing
6.8.1. Global Next Generation Sequencing Market, by De Novo Sequencing, by Region, 2019 – 2032 (USD Billion)
6.9. Methyl Sequencing
6.9.1. Global Next Generation Sequencing Market, by Methyl Sequencing, by Region, 2019 – 2032 (USD Billion)
Global Next Generation Sequencing Market, by Product
7.1. Key Findings
7.2. Introduction
7.2.1. Global Next Generation Sequencing Market, By Product, 2019 – 2032 (USD Billion)
7.3. Instruments
7.3.1. Global Next Generation Sequencing Market, by Instruments, By Region, 2019 – 2032 (USD Billion)
7.4. Reagents & Consumables
7.4.1. Global Next Generation Sequencing Market, by Reagents & Consumables, by Region, 2019 – 2032 (USD Billion)
7.5. Services
7.5.1. Global Next Generation Sequencing Market, by Services, by Region, 2019 – 2032 (USD Billion)
Next Generation Sequencing Market Assessment by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Next Generation Sequencing Market, By End Use, 2019 – 2032 (USD Billion)
8.3. Healthcare Institutions
8.3.1. Global Next Generation Sequencing Market, by Healthcare Institutions, by Region, 2019 – 2032 (USD Billion)
8.4. Academics
8.4.1. Global Next Generation Sequencing Market, by Academics, by Region, 2019 – 2032 (USD Billion)
8.5. Biotech & Pharma Firms
8.5.1. Global Next Generation Sequencing Market, by Biotech & Pharma Firms, by Region, 2019 – 2032 (USD Billion)
8.6. Others
8.6.1. Global Next Generation Sequencing Market, by Others, by Region, 2019 – 2032 (USD Billion)
Regional Analysis
- North America: Leading the global NGS market, North America benefits from substantial investments in research and development, advanced healthcare infrastructure, and the presence of major market players. The region’s focus on integrating NGS into clinical practice has further propelled market growth.
- Europe: Europe is experiencing significant growth due to government funding for genomic research and the development of national genomics initiatives. Collaborative research projects across EU countries are advancing NGS technology and its applications in health and disease.
- Asia-Pacific: Emerging as the fastest-growing region, Asia-Pacific’s market expansion is driven by increasing government initiatives to advance healthcare infrastructure, rising healthcare expenditures, and growing funding for genomic research. Countries like China, Japan, and India are at the forefront of this growth.
- Latin America and Middle East & Africa: These regions are gradually adopting NGS technologies, with growth supported by investments in healthcare infrastructure and increasing awareness of genomic medicine’s benefits.
Key Companies
- BGI
- Bio-Rad Laboratories, Inc.
- DNASTAR, Inc.
- Eurofins GATC Biotech GmbH
- Genomatix GmbH
- Illumina Inc.
- Invitae Corporation
- Oxford Nanopore Technologies
- Perkin Elmer, Inc.
- PierianDx
- Qiagen
- Roche Ltd.
- Thermo Fisher Scientific Inc.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market
Conclusion
The Next Generation Sequencing market is poised for continued growth, driven by technological innovations, expanding applications in clinical diagnostics, and increasing global investments in genomic research. As NGS technologies become more accessible and integrated into healthcare systems, they are set to play a pivotal role in advancing personalized medicine and improving patient outcomes worldwide.
More Trending Latest Reports By Polaris Market Research:
Algorithmic IT Operations (AIOps) Market
Point-of-Use Water Treatment Systems Market